Avance Biosciences
Molecular testing laboratory supporting cell and gene therapy programs with GLP qPCR and ddPCR assays for biodistribution, shedding and vector persistence, plus assay development and validation.
8 contract research organizations in our directory list Biodistribution as a capability, across 4 countries. 4 report GLP capability and 3 report AAALAC accreditation. Compare their species, services and accreditations below, and contact labs directly from their profiles.
Showing 8 CROs. Order rotates daily so no lab is permanently listed first.
Molecular testing laboratory supporting cell and gene therapy programs with GLP qPCR and ddPCR assays for biodistribution, shedding and vector persistence, plus assay development and validation.
Preclinical CRO in West Michigan specializing in targeted CNS delivery. Long track record supporting intrathecal, intracerebroventricular and cisterna magna dosing, CSF and tissue distribution, pharmacokinetics and…
Korean nonclinical pharmacology CRO in the Biotoxtech group offering efficacy studies, PCR-based biodistribution for cell and gene therapies, and GLP bioanalysis.
Biomere (a JOINN company) is a preclinical CRO based in Worcester, MA. Services include non-GLP PK/PD, discovery toxicology, surgical services, disease models, and laboratory sciences. Surgical services include…
Preclinical CRO near Lyon with core expertise in nonhuman primate models, including BSL-3 infectious disease, biodistribution and custom proof-of-concept studies.
Preclinical CRO in Northern Ireland, part of QIMA Life Sciences, running non-GLP rodent PK, dose range finding, biodistribution and disease model studies.
French CRO specializing in analytics for gene and cell therapies, including GLP biodistribution, vector shedding and anti-AAV immunogenicity assays.
Vector design and manufacturing company that also offers AAV biodistribution profiling services, including barcoded multiplex studies in rodents and NHPs.